Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions
Recruiting · NCT06638541 · Registry updated 2026-03-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Not applicable | 2026-03-23 | NCT06638541 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Elekta Limited | 8 |
| MRL Consortium | 3 |
| Royal Marsden NHS Foundation Trust | 89 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sunnybrook Health Sciences Centre | Toronto | Canada | 12 |
| The Christie NHS Foundation Trust | Manchester | United Kingdom | 113 |
| The Royal Marsden NHS Foundation Trust | Sutton | United Kingdom | 3 |